K-Health_MIRAE Initiative

Hong, Kee Jong PM is an infectious disease vaccine expert who earned his Master's in Biology from Seoul National University and his Ph.D. in Science from Texas Tech University.

He gained 8 years of research and administrative experience at the National Institute of Health, Korea Disease Control and Prevention Agency.

After returning to South Korea, he dedicated 20 years to developing vaccines and diagnostic technologies to prepare for infectious disease pandemics, including those for anthrax, avian influenza, and tularemia. In 2022, he was selected as the head of the Novel and Emerging Infectious Disease mRNA Vaccine Project (KmVAC), where he spearheaded domestic mRNA vaccine development. Currently, Dr. Hong is a professor at Gachon University College of Medicine and serves as a PM for Health Security within the K-Health MIRAE Initiative, tasked with developing pandemic response vaccines and treatments.

• Infectious Diseases
• Vaccines
• Treatments
• Pandemic
• Health Security
• Vaccine Sovereignty
• GlobalHub
• mRNA Technology

Kim, Youn Been PM is a global pharmaceutical expert with over 20 years of experience at multinational pharmaceutical companies like Bayer and Novartis.

She graduated from Sookmyung Women's University with a degree in Pharmacy and earned her MBA from Yonsei University.

In 2006, she launched Novartis Venture Fund's Korean investment operations. From 2008 to 2017, as the Head of International Collaboration and Research Operations at the Novartis Institute for Tropical Diseases in Singapore, she successfully facilitated over 500 contracts for infectious disease drug development collaborations.

Since 2018, as the founding CEO of the Global Health Research Fund (RIGHT Fund), she has been leading initiatives to support domestic health technology development aimed at addressing medical inequality in developing countries.

• Unmet Medical Needs
• Intractable Diseases
• Rare Diseases
• Treatments
• Diagnostics
• Vaccines
• Digital Health Technology

Cho, Young Jae PM graduated from Seoul National University College of Medicine in 2002, then earned his Master's in Public Health and Ph.D. in Medicine from the same institution.

Since 2011, he has been a professor in the Division of Pulmonology and Critical Care Medicine at Seoul National University Bundang Hospital, where he is an expert in critical care systems, ECMO, and percutaneous dilatational tracheostomy.

After training in Biomedical Engineering at the University of Pennsylvania and Mechanical Engineering at Seoul National University, he has conducted translational research using patient-derived lung cells, lung-on-a-chip, and organoids for 3D cell culture.

He has also served as a PM for the Advanced Bio division at the Ministry of Trade, Industry and Energy and held various executive positions in academic societies.

Since September 2024, as a PM for Disruptive Biohealth within the K-Health MIRAE Initiative, he has been leading biohealth innovation, including planning South Korea's first space medicine project.

• Advanced Bio
• Innovative Medical Technology
• Translational Medicine
• Space Medicine
• Future Medicine

Yi, Seung Kyu PM is a science and technology policy expert with diverse academic backgrounds including Molecular Biology (B.S., M.S.), an MBA, and Technology Policy (Ph.D.).

He conducted research on angiogenesis and stroke at SK Biopharm. For 19 years at the Korea Institute of S&T Evaluation and Planning (KISTEP), he was responsible for technology forecasting in the bio-healthcare sector and preliminary feasibility studies for national R&D projects.

Since 2018, he has served as the head of the Social Problem Science and Technology Policy Center at the Ministry of Science and ICT, where he established R&D policies for identifying and solving social challenges.

He has also participated in building Korea's HT innovation system as a research commissioner for the Ministry of Health and Welfare's Health and Medical Technology Policy Deliberation Committee.

Since March 2025, as a PM for Future Welfare and Care Revolution within the K-Health MIRAE Initiative, he is tasked with innovating new welfare and care services to improve healthy longevity in a super-aged society.

• AXBased System Innovation
• Preparing For Ultra Aged Society
• Sustainable Care And Welfare
• Healthy Longevity Improvement
• Healthcare And Care Linkage

Chang-Hyun Lee PM has been a professor in the Department of Medical Device Industry at Seoul National University College of Medicine and a professor in the Department of Radiology at Seoul National University Hospital since 2004.

He iradiology expert, evidenced by his development of medical institution radiation dose management software (Dose M) in 2018, which has been exported overseas, and his role as a representative for South Korea at the IAEAs a.

From 2018 to 2022, as the principal investigator for the research project "Structural and Functional Evaluation of Exposure-Related Lung Diseases using CT Image Matching Technology," he established a unique inspiratory-expiratory CT image-based lung disease cohort, conducting international collaborative research.

Currently, as a PM for Essential Health Service within the K-Health MIRAE Initiative, he is responsible for diagnosing environmental lung diseases using functional lung imaging and conducting research on imaging diagnostics using computational fluid dynamics, digital twins, and AI

• Asthma
• Chronic Obstructive Pulmonary Disease
• Lung Cancer
• Essential Healthcare
• Imaging Diagnostics
• AI
• Digital Twin

Park, Mi Sun PM is an expert in advanced biopharmaceuticals and regenerative medicine.

She holds a Ph.D. in Pharmacy from Pusan National University and spent over 10 years establishing the foundation of regulatory science at the Ministry of Food and Drug Safety.

She then conducted cardiovascular disease research for 10 years in the United States at Rutgers Robert Wood Johnson Medical School and Columbia University. Upon returning to South Korea, she served as a research professor at Yonsei University, Head of the Advanced Bioconvergence Research Division at the Ministry of Food and Drug Safety, and Planning Director at the Korea Regulatory Science Center.

In these roles, she oversaw national research projects to establish quality standards and evaluation technologies for novel treatments such as cell and gene therapies, exosomes, and organoids. Currently, as a PM for "Overcoming Unmet Medical Needs" within the K-Health MIRAE Initiative,

She is planning national strategic R&D focused on developing patient-specific treatments for rare and intractable diseases and advanced bio-based translational research.

• Rare And Intractable Diseases
• Cardiovascular Diseases
• Advanced Biopharmaceuticals
• Regenerative Medicine
• Regulatory Science

Lee, Chang Bog PM is a technology management expert with over 30 years of experience at Samsung Electronics Advanced Institute of Technology.

He contributed to research in electronics devices and the development of DVDR and digital printers.

He also enhanced research center operational efficiency by introducing the Matrix organizational system and the Fellow/Master system.

Since 2013, he designed the Samsung Future Technology Incubation Project as a public service initiative and served as the ICT Team Leader, making it Korea's leading R&D fund by selecting over 250 projects and managing the support of over KRW 260 billion in research funding.

Currently, as a PM for Disruptive Biohealth within the K-Health MIRAE Initiative, he is gathering innovative and challenging ideas to secure super-gap technologies to solve healthcare challenges and is promoting R&D that isn't afraid of failure.

• Digital Biohealth
• Medical Twin
• Systems Biology
• Quantum Bio

Lee, Je Wook PM holds a Ph.D. in Microbiology and Molecular Biology from Kyungpook National University.

He developed global-level research capabilities through his postdoctoral work in immunology at UCSF and Dana-Farber Cancer Institute in the United States.

Upon his return to South Korea, he served as a senior researcher at a bio-company and as the head of the Drug Development Support Center at Osong Medical Innovation Foundation. Over more than a decade, he has amassed expertise in the development of vaccines, antibody therapeutics, cell and gene therapies, and the planning of AI-based immunoanalysis platforms

Since May 2025, as a PM for Health Security within the K-Health MIRAE Initiative, he has been driving high-risk, high-impact projects such as the development of universal vaccine platform technology and the establishment of an early infectious disease prediction system.

• Early Infectious Disease Prediction And Rapid Response
• Universal Vaccine Technology Development
• Achieving Medical Equality
• Strengthening Health Security System

Han, Hee Chul PM is a medical expert who majored in medicine and, based on his research experience in human physiological mechanisms, seeks to innovate welfare and care systems using science and technology.

He conducted medical research at Korea University College of Medicine for over 40 years.

He has contributed to setting directions for medical research and nurturing medical researchers by serving on the Ministry of Health and Welfare's Healthcare R&D Strategic Planning Team and as Chairman of the Convergent Physician-Scientist Steering Committee.

Since May 2025, as a PM for Future Welfare and Care Revolution within the K-Health MIRAE Initiative, he is tasked with innovating new welfare and care services to improve the quality of life and healthy longevity in a super-aged society.

• Preparing For Ultra Aged Society
• Sustainable Care And Welfare
• Quality Of Life Improvement
• Healthy Longevity Improvement
• Healthcare And Care Linkage